Wells Fargo’s INmune Bio INMB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $22.4K | Buy |
9,683
+3,165
| +49% | +$7.31K | ﹤0.01% | 5329 |
|
|
2025
Q1 | $50.9K | Buy |
6,518
+141
| +2% | +$1.1K | ﹤0.01% | 4943 |
|
|
2024
Q4 | $29.8K | Buy |
6,377
+2,155
| +51% | +$10.1K | ﹤0.01% | 5154 |
|
|
2024
Q3 | $22.8K | Buy |
4,222
+259
| +7% | +$1.4K | ﹤0.01% | 5207 |
|
|
2024
Q2 | $35K | Buy |
3,963
+3,816
| +2,596% | +$33.7K | ﹤0.01% | 5053 |
|
|
2024
Q1 | $1.73K | Buy |
147
+2
| +1% | +$23 | ﹤0.01% | 5665 |
|
|
2023
Q4 | $1.63K | Sell |
145
-2,219
| -94% | -$25K | ﹤0.01% | 5691 |
|
|
2023
Q3 | $16K | Sell |
2,364
-865
| -27% | -$5.86K | ﹤0.01% | 5310 |
|
|
2023
Q2 | $29.3K | Sell |
3,229
-152
| -4% | -$1.38K | ﹤0.01% | 5332 |
|
|
2023
Q1 | $21.8K | Sell |
3,381
-4,222
| -56% | -$27.3K | ﹤0.01% | 5287 |
|
|
2022
Q4 | $48.2K | Sell |
7,603
-5,075
| -40% | -$32.2K | ﹤0.01% | 4573 |
|
|
2022
Q3 | $78K | Sell |
12,678
-949
| -7% | -$5.84K | ﹤0.01% | 4445 |
|
|
2022
Q2 | $121K | Sell |
13,627
-589
| -4% | -$5.23K | ﹤0.01% | 4282 |
|
|
2022
Q1 | $120K | Buy |
14,216
+2,707
| +24% | +$22.9K | ﹤0.01% | 4911 |
|
|
2021
Q4 | $118K | Buy |
11,509
+8,882
| +338% | +$91.1K | ﹤0.01% | 5152 |
|
|
2021
Q3 | $51K | Buy |
2,627
+2,575
| +4,952% | +$50K | ﹤0.01% | 5312 |
|
|
2021
Q2 | $1K | Hold |
52
| – | – | ﹤0.01% | 6332 |
|
|
2021
Q1 | $1K | Buy |
52
+12
| +30% | +$231 | ﹤0.01% | 6352 |
|
|
2020
Q4 | $1K | Hold |
40
| – | – | ﹤0.01% | 6010 |
|
|
2020
Q3 | $0 | Buy |
40
+17
| +74% | – | ﹤0.01% | 6184 |
|
|
2020
Q2 | $0 | Buy |
23
+1
| +5% | – | ﹤0.01% | 6114 |
|
|
2020
Q1 | $0 | Buy |
+22
| New | – | ﹤0.01% | 6077 |
|